What is NOT a requirement for administering Magnesium Sulfate to a pre-eclamptic/eclamptic patient?

Administering Magnesium Sulfate to a pre-eclamptic or eclamptic patient does not have an age restriction, meaning that the patient's age being less than 55 years old is not a requirement for treatment. Magnesium Sulfate is used primarily to prevent seizures in women experiencing severe hypertension or eclampsia, regardless of their age.

In contrast, other factors are critical when considering the administration of Magnesium Sulfate. A history of hypertension is relevant as it helps establish the patient’s risk for pre-eclampsia or eclampsia. The presence of seizures is also a direct indication for administering Magnesium Sulfate, as its primary purpose in this context is to manage and prevent seizures associated with these conditions. Furthermore, monitoring vital signs is essential to ensure patient safety and to observe for any adverse reactions to the medication.